Population pharmacokinetic model of fluvoxamine in rats: Utility for application in animal behavioral studies
- 31 January 2007
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 30 (1) , 45-55
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Population pharmacokinetics of APOMINE™: A meta‐analysis in cancer patients and healthy malesBritish Journal of Clinical Pharmacology, 2004
- Pharmacodynamic Analysis of the Interaction between Tiagabine and Midazolam with an Allosteric Model That Incorporates Signal TransductionEpilepsia, 2003
- Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug developmentEuropean Journal of Drug Metabolism and Pharmacokinetics, 2000
- A Population Pharmacokinetic–Pharmacodynamic Analysis of Repeated Measures Time-to-Event Pharmacodynamic Responses: The Antiemetic Effect of OndansetronJournal of Pharmacokinetics and Biopharmaceutics, 1999
- Bootstrap resampling: a powerful method of assessing confidence intervals for doses from experimental dataPhysics in Medicine & Biology, 1999
- Pharmacokinetic–pharmacodynamic modelling of behavioural responsesNeuroscience & Biobehavioral Reviews, 1998
- Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysisLife Sciences, 1994
- Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis studyEuropean Journal of Pharmacology, 1992
- Designs for population pharmacodynamics: Value of pharmacokinetic data and population analysisJournal of Pharmacokinetics and Biopharmaceutics, 1991
- The Biochemistry of Affective DisordersThe British Journal of Psychiatry, 1967